Skip to main content
Premium Trial:

Request an Annual Quote

Human Longevity Completes $220M Series B Financing

NEW YORK (GenomeWeb) – Human Longevity announced on Monday that it has completed a $220 million offering of Series B preferred stock.

The firm plans to use the proceeds to grow its business and expand its product offerings, including Health Nucleus, a comprehensive, genomic-enhanced, research-based health center; ongoing development of the HLI Knowledgebase which currently has more than 20,000 complete genomes coupled with phenotype data; the Comprehensive Cancer Program; and other sequencing programs.

Investors in this financing round include Illumina, Celgene, GE Ventures, and participants in the $80 million Series A round the firm closed in 2014.

"The closing of our Series B offering was completed with excellent results for HLI, despite especially challenging external financial markets," said Co-founder and CEO J. Craig Venter in a statement. "This is a tribute to the strength of our science, technology, and team. We continue to build our business, develop life-changing products, and hire world-class scientific, clinical, and technical leaders to help us meet our goal of revolutionizing healthcare."

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.